GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

PHASE3TerminatedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

December 31, 2006

Conditions
Type 2 Diabetes
Interventions
DRUG

Tesaglitazar

Trial Locations (42)

Unknown

Research Site, Hasselt

Research Site, Liège

Research Site, Sint-Gillis-Waas

Research Site, Steenokkerzeel

Research Site, Shatin

Research Site, Balatonfüred

Research Site, Budapest

Research Site, Kaposvár

Research Site, Kecskemét

Research Site, Székesfehérvár

Research Site, Gubbio

Research Site, Milan

Research Site, Perugia

Research Site, Piacenza

Research Site, Reggio Emilia

Research Site, Udine

Research Site, Kubang Kerian

Research Site, Kuala Lumpur

Research Site, Makati City

Research Site, Manila

Research Site, Pasig

Research Site, Krakow

Research Site, Lublin

Research Site, Płock

Research Site, Torun

Research Site, Tychy

Research Site, Warsaw

Research Site, £ód?

Research Site, Banská Bystrica

Research Site, Bratislava

Research Site, Ilava

Research Site, Košice

Research Site, Kysucké Nové Mesto

Research Site, Lučenec

Research Site, Ľubochňa

Research Site, Nitra

Research Site, Prešov

Research Site, Trnava

Research Site, Johannesburg

Research Site, Cape Town

Research Site, Durban

Research Site, Bangkok

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY